Skip to main content
. 2022 Mar 28;25:264–277. doi: 10.1016/j.omtm.2022.03.017

Table 3.

Biomarker selection and prioritization based on reagent availability, cross-reactivity, and detection in dorsal root ganglia

Biomarker Cell type specificity Reagent availability
Cross-reactivity
Detected in DRGs
MSD R-plex kit Antibodies Protein standard Monkey Rat
UCH-L1 Neurons F211O (human) Included in kit Included in kit Yes Yes Yes
NF-L Neurons (axons) F217X (human) Included in kit Included in kit Yes Yes Yes
IBA1 Microglia Not available Abcam (ab178846) Abcam (ab178847) Abcam (ab105593) Yes Yes Yes
CNPase Oligodendrocytes Not available Millipore (MAB326)
CST (5664)
Requires custom synthesis Yes Yes Yes
MAP2 Neurons (dendrites) Not available PhosphoSolutions (1099-MAP2) Requires characterization & custom synthesis Yes Yes Yes
GFAP Astrocytes F211M (human) Included in kit Included in kit Yes Yes No
Tau (total) Neurons (axons) F218D (human) F228E (mouse) Included in kit Included in kit Noa Yesa No
a

For analysis of total Tau, monkey samples were tested using the human kit (F218D) and rat samples were tested using the mouse kit (F228E).